MitraClip intervention as rescue therapy in cardiogenic shock: one-year follow-up.
The MitraClip (Abbott Vascular, Menlo Park, CA) is a device used to perform transcatheter edge-to-edge repair of the mitral valve approved by the Food and Drug Administration for the treatment of high-risk degenerative mitral regurgitation. We describe the follow up of a 78-year-old man with severe functional mitral regurgitation and cardiogenic shock who underwent a successful MitraClip implantation.